Dare Bioscience DARE
NASDAQ DARE
$0.68 -0.01 (-1.26%)
As of: Oct 21, 2026 · 3:49 PM EDT

Dare Bioscience (DARE) Acquisitions (2018 - 2019)

Updated

Dare Bioscience's Acquisitions came in at $6.14 million for Q4 2019, compared with -$507,000 a year earlier.

Analysis

Dare Bioscience (DARE) Acquisitions (2018 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -17.24 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.21 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Dare Bioscience 10.13 Mn -55.33 Mn -132,343.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -6.14 Mn
Sep 30, 2018 55,000.00
API Access

Dare Bioscience Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=DARE&period=max&api_key=YOUR_API_KEY